THIRD DAY
Friday September 29th
8.30-10.0 Session V: TUMOR MICROENVIRONMENT
8.30-9.00: Spatial transcriptomics reveals a substantial heterogeneity in TNBC tumor and stroma compartments with potential clinical implications,
Pr Christos Sotiriou, ULB, B
9.00-9.30: Immune contexture of radiation response:
Dr Jerome Galon, Cordeliers Research Center, FR
9.30-10.00: Reprogramming the tumour microenvironment to improve responses to radiotherapy,
Pr Tim Illidge, Manchester Cancer Research Center, UK
10.00-10.30 Coffee break
10.30-12.30 Session VI: AI, IMAGING AND RADIOMICS
10.30-11.00: Innovative approaches to trigger radiation induced immunological cell death and overcome checkpoint resistance,
Pr Jim Welsh, MD Anderson Cancer Center, USA
11.00-11.30: The role of standard imaging in radio-immunotherapy: focus on radiomics and lymphocyte sparing radiotherapy,
Pr Philippe Lambin, Maastricht University, NL
11.30-12.00: Predictive and prognostic role of PET in immunotherapy,
Dr Désirée Deandreis, Gustave Roussy, FR
12.00-12.30: Next generation radiotherapy at the era of AI and immunotherapy,
Pr Eric Deutsch, Gustave Roussy, FR
12.30-14.00 Lunch break and exhibition
14.00-16.00 Session VII: ADAPTIVE IMMUNITY
14.00-14.30: Fatty Acid metabolic regulation of anti-tumor immunity against irradiated glioblastoma,
Dr Claire Vanpouille-Box, Weill Cornell Medicine, US
14.30-15.00: Human endogenous retroviruses represent a source of shared tumor epitopes for cancer immunotherapy,
Pr Stephane Depil, Centre Leon Berard, FR
15.00-15.30: Targeting IL2 signaling with radiotherapy to trigger systemic immunity,
Pr Sana Karam, University of Colorado, USA
15.30-16.00: Impact of radiation on intestinal commensals and cancer immunosurveillance,
Pr Laurence Zitvogel, Gustave Roussy, FR
16.00-16.30 Coffee break
16.30-17.30 Session VIII: INNATE IMMUNITY
16.30-17.00: In situ abscopal effect: synergistic efficacy of immunotherapy and partial tumor irradiation,
Dr Michele Mondini, Gustave Roussy, FR
17.00-17.30: Photon and particle radiation antitumor immune effects via senescence and NK cells,
Pr Peter Hüber, German Cancer Research Center, G
19.30-00.00 GALA DINNER
